Cetera Investment Advisers’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-501
Closed -$54.2K 4088
2025
Q1
$54.2K Buy
+501
New +$43.6K ﹤0.01% 3847
2024
Q4
Sell
-400
Closed -$39.3K 3769
2024
Q3
$39.3K Sell
400
-886
-69% -$114K ﹤0.01% 3615
2024
Q2
$210K Buy
1,286
+132
+11% +$18.8K ﹤0.01% 3326
2024
Q1
$176K Buy
+1,154
New +$192K ﹤0.01% 3383

Other funds holding AGL

Cetera Investment Advisers's AGL Position: Q2 2025 in Review

Cetera Investment Advisers sold out of Agilon Health (AGL) in Q2 2025, closing a stake of 501 shares — an estimated $54.2K sold.

Cetera Investment Advisers first reported a position in AGL in Q1 2024 and held it in 4 quarters. The position peaked at $210K in Q2 2024. 205 funds tracked by Wall St. Rank hold AGL as of Q2 2025.

  • Cetera Investment Advisers reported no remaining Agilon Health position as of Q2 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 501 Agilon Health shares in Q2 2025, an estimated $54.2K.
  • Cetera Investment Advisers first reported a position in Agilon Health in Q1 2024 and held it in 4 quarters.
  • Cetera Investment Advisers's Agilon Health position peaked at $210K in Q2 2024.
  • 205 funds tracked by Wall St. Rank held Agilon Health as of Q2 2025.

Based on Cetera Investment Advisers's 13F filing for Q2 2025, filed 8 Aug 2025.